Using AI to create personalized treatments for chronic rhinosinusitis.
The Chronic Rhinosinusitis (CRS) Problem and an AI Driven Personalized Medicine Solution
This study is looking at how we can use artificial intelligence to create personalized treatment plans for people with chronic rhinosinusitis (CRS) to help improve their symptoms and overall health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-11023120 on NIH RePORTER |
What this research studies
This research focuses on chronic rhinosinusitis (CRS), a common condition that significantly impacts quality of life due to symptoms like nasal blockage, loss of smell, and recurrent infections. The study aims to utilize artificial intelligence to analyze individual patient data and develop personalized treatment plans that address the unique disease trajectories of CRS patients. By understanding how CRS affects overall health and its relationship with other respiratory diseases, the research seeks to improve treatment outcomes and patient satisfaction. Patients will be closely monitored to assess the effectiveness of these tailored approaches over time.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who are diagnosed with chronic rhinosinusitis and experience significant symptoms.
Not a fit: Patients with acute rhinosinusitis or those who do not have chronic symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients suffering from chronic rhinosinusitis.
How similar studies have performed: Previous research has shown promise in using AI for personalized medicine in other chronic conditions, indicating potential success for this approach in CRS.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Ramakrishnan, Vijay — Indiana University Indianapolis
- Study coordinator: Ramakrishnan, Vijay
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.